IPP Bureau
Barentz appoints Daniel Hitz as CEO, APAC
By IPP Bureau - January 07, 2022
Hitz shall assume new role from January 17th, 2022
Aurobindo Pharma rolls out Molnaflu in India
By IPP Bureau - January 06, 2022
The brand is now available pan-India through their distribution partner
Yashoda Hospitals performs region’s first double-lung transplant
By IPP Bureau - January 06, 2022
After double lung transplantation, he was discharged without supplemental oxygen on the eleventh day
Margins under pressure; domestic market growth to slow down: Nirmal Bang
By IPP Bureau - January 06, 2022
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
Biotium introduces unique super-sensitive RNA Prestain Loading Dye
By IPP Bureau - January 06, 2022
EMBER500RNA Prestain Loading Dye allows single-step denaturing, loading, and bright RNA staining on regular agarose gels
Thermo Fisher Scientific acquires PeproTech for US $1.85 bn
By IPP Bureau - January 06, 2022
PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products
NATHEALTH Home Care Forum launches white paper on healthcare delivery
By IPP Bureau - January 06, 2022
10 implementation focused initiatives recommended to accelerate policy reforms, standardization of home care delivery services, and improve accessibility and affordability of care in tier II and tier III geographies
ENTOD Pharmaceuticals set to launch Molentod
By IPP Bureau - January 06, 2022
It is the generic version of molnupiravir
U.S. FDA grants approval for Alembic’s Parkinson’s drug
By IPP Bureau - January 06, 2022
Entacapone tablets USP, 200 mg have an estimated market size of US$ 10.5 million for twelve months ending September 2021, according to IQVIA
Dr. K.V.S Ram Rao is the new JMD & CEO of Granules India
By IPP Bureau - January 05, 2022
He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management
Biogen exercises option with Ionis for spinal muscular atrophy
By IPP Bureau - January 05, 2022
Biogen paid Ionis a US $ 60 million one-time upfront payment
Jemincare confirms its antibody effective against Omicron
By IPP Bureau - January 05, 2022
The latest research results indicated that JMB2002 had high binding activity to the Omicron variant and showed potent Omicron pseudovirus neutralization function
Bharat Biotech's intranasal vaccine Phase 3 trials gets approval
By IPP Bureau - January 05, 2022
It has also been granted permission to conduct trials for booster dose
Tata Medical develops OmiSure to detect Omicron
By IPP Bureau - January 05, 2022
The test kit is compatible with all standard Real-Time PCR machines with a test run time of 85 minutes. The result turnaround time, including sample collection and RNA extraction, is 130 minutes
Dassault Systèmes to showcase the Virtual Twin Experience of the human body at CES 2022
By IPP Bureau - January 04, 2022
The virtual world makes it possible to visualize, test, understand and predict what cannot be seen, before a patient is treated
